FNY Investment Advisers’s Amedisys AMED Stock Holding History

FNY Investment Advisers’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,750	Closed	-$664K	–	1221
2025 Q2	$664K	Buy	6,750 +1,750	+35%	+$166K	0.28%	100
2025 Q1	$463K	Buy	+5,000	New	+$461K	0.28%	78
2024 Q3	–	Sell	-12,000	Closed	-$1.1M	–	671
2024 Q2	$1.1M	Buy	+12,000	New	+$1.11M	0.74%	33
2023 Q4	–	Sell	-2,000	Closed	-$187K	–	471
2023 Q3	$186K	Buy	+2,000	New	+$185K	0.11%	114
2019 Q1	–	Sell	-90	Closed	-$10K	–	705
2018 Q4	$10K	Buy	+90	New	+$10.6K	﹤0.01%	406

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FNY Investment Advisers's AMED Position: Q3 2025 in Review

FNY Investment Advisers sold out of Amedisys (AMED) in Q3 2025, closing a stake of 6,750 shares — an estimated $664K sold.

FNY Investment Advisers first reported a position in AMED in Q4 2018 and held it in 5 quarters. The position peaked at $1.1M in Q2 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

FNY Investment Advisers reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
FNY Investment Advisers sold 6,750 Amedisys shares in Q3 2025, an estimated $664K.
FNY Investment Advisers first reported a position in Amedisys in Q4 2018 and held it in 5 quarters.
FNY Investment Advisers's Amedisys position peaked at $1.1M in Q2 2024.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.